• Communications

    Posted in category News by Communications on 18/02/2014

    ABPI annual conference and dinner 2014

This year's conference is on 'Securing a future for innovative medicines' and is taking place on Thursday 10 April at the Westminster Bridge Park Plaza, London.


​The UK has one of the poorest records on the adoption and diffusion of innovation within our healthcare system.  This has a significant impact on patient outcomes and the very sustainability of the system that the nation treasures. Combined with the slow adoption the UK also has one of the most effective genericisation markets, this is overlaid by a crisis in public spending driven by Government deficits. This challenge is reflected in the latest PPRS that aims to transform the UK landscape on the adoption and diffusion of much needed innovation.

At the same time we see the medicines development paradigm shifting.  The commercial world along with the research and development environments will inevitably come together as we move towards more pre-competitive collaboration, a more pragmatic approach to clinical development of medicines and regulators/ HTA bodies working closer together on the evaluation and appraisal of medicines.  In addition, the NHS is moving towards an era of greater transparency, a wider use of real world data and a keen focus on improved outcomes for patients. 

In this new and evolving world our annual conference will take a look at how we can secure a future for innovative medicines here in the UK and what in particular this will mean for the patient.  Our expert speakers and panellists will share their insights in to how they see the drug development world changing and how industry and the NHS must respond. 

This conference is a must for anyone operating in the UK commercial environment and suitable for any member of the industry from senior managers, market access, communications, commercial and account management.

Topics include:

  • The innovation landscape – future of medicines
  • The NHS, looking to the future 
  • The future for the patient
  • The future for value assessments
  • The future for specialised commissioning
  • The vision for the uptake of medicines
  • The patient response

Speakers confirmed so far: (more to be added).

  • Miles Ayling, Director of Innovation, NHS England
  • Alastair Campbell, writer, communicator and strategist
  • Dr Penny Dash, Director, McKinsey
  • Sir Andrew Dillon, Chief Executive, NICE
  • Lord Howe, Parliamentary Under Secretary of State for Quality, Department of Health
  • Deepak Khanna, ABPI President
  • Stephen Whitehead, ABPI Chief Executive

For more information and to register, go to the annual conference and dinner registration site, or contact Ivan Dennie, ABPI Events Manager at  idennie@abpi.org.uk.  

Print this page icon Print this page
Please choose the subject of your enquiry from the list below:
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.